Arnold & Porter‘s life sciences team is bolstered by the arrival of Fabien Roy from Hogan Lovells International LLP who brings extensive expertise in navigating the complex EU regulatory frameworks within medical device and pharmaceutical regulatory matters.

Bird & Bird is called upon by market-leading corporations to advise on complex, business-critical regulatory and commercial matters. The team has recently supported clients in relation to key EU initiatives, including draft proposals under the EHDS, the Critical Medicines Act and the Pharma Package. The practice demonstrates strength in pharmaceutical and regulatory litigation. Practice head Marc Martens covers the full lifecycle of medicinal product and biomedical device development. Kevin Munungu brings deep expertise in EU regulatory and procurement matters, while Benedicte Mourisse advises on core life sciences regulatory issues.

Boasting experience with mandates ranging from settlement and distribution agreements to parallel imports and emerging digital health issues, Crowell & Moring advises clients on the full spectrum of pharmaceutical regulatory issues. Practice head Kristof Roox combines IP litigation experience with regulatory expertise across the pharmaceuticals and medical sectors, while Jurgen Figys‘ biomedical background and deep knowledge of life sciences regulation strengthen the team’s offering.

IP and life sciences regulatory boutique, HOYNG ROKH MONEGIER, advises on the entire lifecycle of medicinal product and device development, combining high-level regulatory support with market-leading IP expertise. The team handles EU and national regulatory matters and is experienced in disputes heard before European and domestic courts. Practice head Liesbeth Weynants possesses extensive experience in patent litigation and regulatory matters. She is also recognised for her contributions to addressing unfair competition, privacy, and data protection issues within the life sciences sector.

Sidley Austin LLP has strong relationships with EU institutions and regulators and is reputed for its depth of expertise in enforcement, competition, trade and data privacy mandates. Its esteemed clientbase consists of pharmaceutical, biotechnology, medical device and life science clients. Practice head Maurits Lugard brings deep insight from his prior experience at the European Commission. Maarten Meulenbelt focuses on EU regulatory, litigation and competition issues, while Michele Tagliaferri is highly experienced in compliance mandates. Josefine Sommers regularly assists clients with GMP/GCP and EMA procedures. He is adept at handling lifecycle strategy and promotional issues, offering particular expertise in cell and gene therapy matters.

Simmons & Simmons is known for its digital health, biopharmaceuticals and medical device sector expertise, acting for manufacturers, distributors and importers in both cross-border and domestic mandates. The team has a wealth of regulatory experience and regularly assists with legislative development efforts.  Co-heads Olivier Mignolet and Annabelle Bruyndonckx benefit from significant healthcare regulatory expertise and are active in clinical trial, compliance and promotion mandates.  Jérémie Doornaert advises on commercial and data protection matters for life science clients, while Nele Jonckers provides regulatory guidance and coordinates multinational compliance projects. Jérémie Doornaert advises on commercial and data protection matters for life science clients, while Nele Jonckers provides regulatory guidance and frequently coordinates multinational compliance projects.

A&O Shearman’s life sciences team advises clients across the entire product development lifecycle, from approvals and pricing to marketing, data exclusivity and procurement. The team also has strong IP and patent litigation capabilities and benefits from an extensive multi-jurisdictional reach from the Belgium office. Practice head Tine Carmeliet guides pharmaceutical, medical device, and biotech clients through complex EU regulatory procedures.

Hogan Lovells International LLP team in Brussels is well placed to advise on EU, Belgian, French, and Portuguese law. The practice offers comprehensive support to pharmaceutical, medical device, and healthcare clients across regulatory, IP, product liability, and data protection matters. Cláudia Mendes Pinto advises on a wide range of regulatory and commercial issues. Practice head Fabien Roy left the firm in January 2026.

Jones Day has a strong presence in the digital health sector, advising on telemedicine, digital products, AI, and big data solutions. The team, which boasts robust litigation capabilities and a pan-European reach, supports clients seeking to navigate new regulatory frameworks. Practice head Cristiana Spontoni advises pharmaceutical and medical device companies on legal, regulatory, and compliance matters. Jörg Hladjk and Philipp Werner are of note, bolstering the team further with extensive experience in the digital health sector.

Osborne Clarke advises a range of life sciences clients, from scale-ups to multinational corporations, on various EU regulatory and quality matters. Their expertise extends to medical device, product and digital health mandates. The team assists with EU-wide quality systems, regulatory standards, market entry strategies and good manufacturing practices. Practice head Vladimir Murovec focuses exclusively on the healthcare sector and is recognised for his compliance expertise. Other notable names include Louis Hoffreumon and Fjoralba Spahiu.

ALTIUS houses a life science team which boasts significant contentious, regulatory and transactional expertise. Its esteemed clientbase includes pharmaceutical, healthcare and biotech entities, who are active across several jurisdictions. Co-heads Christophe Ronse and Philippe de Jong bring deep IP and patent expertise, while Kirian Claeyé focuses on a wide array of regulatory issues related to clinical trials, market launch strategies and life cycle management.

Reed Smith advises pharmaceuticals, biotech and digital health clients, assisting them with their regulatory obligations from the initial product development to marketing and enforcement. Practice head Wim Vandenberghe focuses on regulatory pathways, product classification and marketing authorisations, and also assists with regulatory due diligence and post-acquisition integration in the life sciences sector.

Stibbe assists clients with complex regulatory issues in the life sciences sector, drawing on close collaboration with its competition, IT and public law practice groups. The team combines expertise in compliance, litigation and product registration. Co-head Ignace Vernimme represents clients before regulators and courts in high-stakes matters, while Philippe Campolini brings strong IP and life sciences experience to serve the needs of Belgian and international clients.